Impact of drug-eluting stents on treatment option mix for coronary artery disease in Japan

Circulation Journal

Volumn 74, Issue 8, 2010, Pages 1635-1643

  Horiguchi, Hiromasa ^a   Yasunaga, Hideo ^a   Hashimoto, Hideki ^a   Matsuda, Shinya ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Coronary artery bypass grafting; Drug eluting stent; Percutaneous coronary intervention

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BARE METAL STENT; CONSENSUS DEVELOPMENT; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OFF PUMP CORONARY SURGERY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; TEACHING HOSPITAL; TREATMENT RESPONSE; TREND STUDY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DATABASES, FACTUAL; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; JAPAN; MALE; MYOCARDIAL INFARCTION;

EID: 77955072985     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0061     Document Type: Article

References (35)

1. Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: Operative technique. Ann Tho-rac Surg 1968; 5: 334-339.
2. Barner HB. Operative treatment of coronary atherosclerosis. Ann Thorac Surg 2008; 85: 1473-1482.
3. Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1978; 1: 263-263.
4. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery and angio-plasty in patients with multivessel disease. N Engl J Med 1996; 335: 217-225.
5. Henderson RA, Pocock SJ, Sharp SJ, Nanchahal K, Sculpher MJ, Buxton MJ, et al. Long-term results of RITA-1 trial: Clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Lancet 1998; 352: 1419-1425.
6. Bittl JA. Advances in coronary angioplasty. N Engl J Med 1996; 335: 1290-1302.
7. Serruys PW, Kutryk MJB, Ong ATL. Coronary-artery stents. N Engl J Med 2006; 354: 483-495.
8. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, et al. Long-term safety and effcacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: A meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008; 118: 1146-1154.
9. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, et al. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation 2008; 118: S199-S209.
10. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
11. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
12. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, et al. Drug-eluting stents vs. coronary-artery bypass grafting in mul-tivessel coronary disease. N Engl J Med 2008; 358: 331-341.
13. Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, et al. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 2008; 117: 2079-2086.
14. Yan Q, Changsheng M, Shaoping N, Xiaohui L, Junping K, Qiang L, et al. Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multi-vessel disease involving signifcant proximal stenosis in left anterior descending artery. Circ J 2009; 73: 1848-1855.
15. Wang ZJ, Zhou YJ, Liu YY, Shi DM, Zhao YX, Guo YH, et al. Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease. Circ J 2009; 73: 1228-1234.
16. Maisel WH. Unanswered questions: Drug-eluting stents and the risk of late thrombosis. N Engl J Med 2007; 356: 981-984.
17. Liddicoat JR, De La Torre R, Ho KK, Nathan S, Levitsky S, Krempin J, et al. Initial impact of drug-eluting stents on coronary artery bypass graft surgery. Ann Thorac Surg 2006; 81: 1239-1242.
18. Kanemitsu S, Tanaka K, Tanaka J, Suzuki H, Kinoshita T. Initial clinical impact of drug eluting stents on coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg 2007; 6: 632-635.
19. Grilli R, Guastaroba P, Taroni F. Effect of hospital ownership status and payment structure on the adoption and use of drug-eluting stents for percutaneous coronary interventions. CMAJ 2007; 176: 185-190.
20. Clark MA, Bakhai A, Lacey MJ, Pelletier EM, Cohen DJ. Clinical and economic outcomes of percutaneous coronary interventions in the elderly: An analysis of medicare claims data. Circulation 2004; 110: 259-264.
21. Movahed MR, Ramaraj R, Hashemzadeh M, Jamal MM, Hashemzadeh M. Rate of acute ST-elevation myocardial infarction in the United States from 1988 to 2004 (from the Nationwide Inpa-tient Sample). Am J Cardiol 2009; 104: 5-8.
22. Kuwabara K, Matsuda S, Imanaka Y, Fushimi K, Hashimoto H, Ishikawa KB, et al. Injury severity score, resource use, and outcome for trauma patients within a Japanese administrative database. J Trauma 2010; 68: 463-470.
23. Kuwabara K, Imanaka Y, Matsuda S, Fushimi K, Hashimoto H, Ishikawa KB, et al. Impact of age and procedure on resource use for patients with ischemic heart disease. Health Pol 2008; 85: 196-206.
24. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defning comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-1139.
25. Nishigaki K, Yamazaki T, Fujiwara H. for the Japanese Coronary Intervention Study (JCIS) Group. Assessment of coronary intervention in Japan from the Japanese Coronary Intervention Study (JCIS) Group. Circ J 2004; 68: 181-185.
26. Osaka S. Historical background and current problems of OPCAB in Japan and some candid advice. Ann Thorac Cardiovasc Surg 2007; 13: 69-72.
27. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multi-vessel coronary artery disease: Six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008; 118: 381-388.
28. Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007; 116(Suppl I): 200-206.
29. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
30. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008; 358: 1781-1792.
31. Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schomig A, et al. Drug eluting and bare metal stents in people with and without diabetes: Collaborative network meta-analysis. BMJ 2008; 337: a1331.
32. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120: 2271-2306.
33. Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008; 358: 342-352.
34. Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 2007; 297: 1992-2000.
35. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297: 2001-2009.